Watson Pharmaceuticals Financial Statements
Watson Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Watson Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 2,496.6 | 1,979.2 | 1,646.2 |
| Gross Profit ($ mil.) | 991.9 | 745.8 | 793.8 |
| Operating Income ($ mil.) | 255.7 | (422.1) | 218.5 |
| Total Net Income ($ mil.) | 141.0 | (445.0) | 138.2 |
| Diluted EPS (Net Income) | 1.27 | (4.37) | 1.21 |
Watson Pharmaceuticals Quarterly Statements
| Quarter Ending Sep 08 | Quarter Ending Jun 08 | Quarter Ending Mar 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 640.7 | 622.6 | 627.0 |
| Gross Profit ($ mil.) | 254.0 | 262.7 | 246.9 |
| Operating Income ($ mil.) | 86.9 | 99.0 | 82.0 |
| Total Net Income ($ mil.) | 71.1 | 60.3 | 50.6 |
| Diluted EPS (Net Income) | 0.62 | 0.53 | 0.45 |
Watson Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.99 | 2.19 | 0.94 |
| Price/Earnings Ratio | 11.05 | 10.78 | 10.50 |
| Price/Book Ratio | 1.21 | 1.67 | 0.89 |
| Price/Cash Flow Ratio | 6.04 | 8.97 | 5.93 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Watson Pharmaceuticals Financial Ratios
Watson Pharmaceuticals Competitive Intelligence
| Barr Pharmaceuticals | Mylan | Teva Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2,500.6 | 1,611.8 | 9,408.0 |
| Employees | 8,900 | -- | -- |
| Market Cap ($ mil.) | 7,117.5 | 2,742.5 | -- |
Competitive Landscape
